title: CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors.
abstract: Etk is a non-receptor tyrosine kinase, which provides a strong survival signal in human prostate cancer cells. Src, another tyrosine kinase that cross-activates with Etk, has been shown to play an important role in prostate cancer metastasis. Herein, we discovered a new class of Etk inhibitors. Within those inhibitors, CTA095 was identified as a potent Etk and Src dual inhibitor. CTA095 was found to induce autophagy as well as apoptosis in human prostate cancer cells. In addition, CTA095 inhibited HUVEC cell tube formation and "wound healing" of human prostate cancer cells, implying its role in inhibition of angiogenesis and metastasis of human prostate cancer. More interestingly, CTA095 could overcome Src inhibitor resistance in prostate cancer cells. It induces apoptosis in Src inhibitor resistant prostate cancer cells, likely through a mechanism of down regulation of Myc and BCL2. This finding indicates that simultaneously targeting Etk and Src could be a promising approach to overcome drug resistance in prostate cancer.
authors: Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, California, United States of America.
authors: Wenchang
authors: W
authors: Guo
authors: Ruiwu
authors: R
authors: Liu
authors: Gaurav
authors: G
authors: Bhardwaj
authors: Ai-Hong
authors: AH
authors: Ma
authors: Chun
authors: C
authors: Changou
authors: Joy C
authors: JC
authors: Yang
authors: Yuanpei
authors: Y
authors: Li
authors: Caihong
authors: C
authors: Feng
authors: Yan
authors: Y
authors: Luo
authors: Anisha
authors: A
authors: Mazloom
authors: Eduardo
authors: E
authors: Sanchez
authors: Yan
authors: Y
authors: Wang
authors: Wenzhe
authors: W
authors: Huang
authors: Randen
authors: R
authors: Patterson
authors: Christopher P
authors: CP
authors: Evans
authors: Kit S
authors: KS
authors: Lam
authors: Hsing-Jien
authors: HJ
authors: Kung
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D001572:Benzofurans / Q000494:pharmacology*; D001665:Binding Sites; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D004195:Disease Models, Animal; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D004789:Enzyme Activation / Q000187:drug effects; D061307:Human Umbilical Vein Endothelial Cells / Q000187:drug effects; D006801:Humans; D008297:Male; D051379:Mice; D008958:Models, Molecular; D010766:Phosphorylation / Q000187:drug effects; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000473:pathology; D011485:Protein Binding; D011487:Protein Conformation; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000737:chemistry; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors; D016271:Proto-Oncogene Proteins c-myc / Q000037:antagonists & inhibitors; D011810:Quinoxalines / Q000494:pharmacology*; D050796:STAT3 Transcription Factor / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D023041:Xenograft Model Antitumor Assays; D019061:src-Family Kinases / Q000037:antagonists & inhibitors* / Q000737:chemistry
chemical_list: C000591537:2-(dibenzo(b,d)furan-2-yl)-7-phenyl-1-(3-(piperidin-1-yl)propyl)-1H-imidazo(4,5-g)quinoxalin-6(5H)-one; D001572:Benzofurans; D019253:Proto-Oncogene Proteins c-bcl-2; D016271:Proto-Oncogene Proteins c-myc; D011810:Quinoxalines; D050796:STAT3 Transcription Factor; D000255:Adenosine Triphosphate; C492367:BMX protein, human; D011505:Protein-Tyrosine Kinases; D019061:src-Family Kinases; D051057:Proto-Oncogene Proteins c-akt
references: Anal Biochem. 1999 Mar 15;268(2):318-29
references: 10075822
references: J Comput Chem. 2005 Dec;26(16):1781-802
references: 16222654
references: Mol Pharmacol. 2012 Nov;82(5):938-47
references: 22899868
references: Mol Cell Biol. 2000 Mar;20(6):2043-54
references: 10688651
references: J Comput Chem. 2011 Aug;32(11):2359-68
references: 21541964
references: Mol Pharm. 2012 Jun 4;9(6):1727-35
references: 22530955
references: Cancer Res. 2010 Jul 1;70(13):5587-96
references: 20570899
references: J Biol Chem. 2001 May 25;276(21):17672-8
references: 11278797
references: Oncogene. 2002 Dec 12;21(57):8817-29
references: 12483534
references: Genes Cancer. 2010 Jan;1(1):40-9
references: 20811583
references: Cancer Biol Ther. 2011 Apr 1;11(7):690-8
references: 21339702
references: Bioinformatics. 2005 Apr 1;21(7):951-60
references: 15531603
references: Oncogene. 1997 Nov 27;15(22):2705-16
references: 9400997
references: Nat Rev Drug Discov. 2006 Oct;5(10):835-44
references: 17016424
references: Science. 2007 Oct 12;318(5848):287-90
references: 17872411
references: Oncogene. 1999 Jun 3;18(22):3391-8
references: 10362360
references: J Mol Graph. 1996 Feb;14(1):33-8, 27-8
references: 8744570
references: Cancer Cell. 2011 Apr 12;19(4):498-511
references: 21481791
references: Cancer Res. 2000 Jun 15;60(12):3137-42
references: 10866300
references: Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W244-8
references: 15980461
references: Cancer Res. 2006 Aug 15;66(16):8058-64
references: 16912182
references: Neoplasia. 2007 Feb;9(2):90-100
references: 17357254
references: Anal Biochem. 1996 Mar 1;235(1):107-9
references: 8850556
references: ChemMedChem. 2007 Jan;2(1):58-61
references: 17154430
references: Biomaterials. 2011 Sep;32(27):6633-45
references: 21658763
references: Genes Dev. 2007 Nov 15;21(22):2861-73
references: 18006683
references: Nucleic Acids Res. 2011 Jul;39(Web Server issue):W270-7
references: 21624888
references: Nature. 1991 Nov 7;354(6348):82-4
references: 1944576
references: Cancer Res. 2009 Jan 15;69(2):700-8
references: 19147587
references: Eur J Cancer. 2010 Feb;46(3):636-41
references: 20004564
references: J Med Chem. 2012 May 24;55(10):4539-50
references: 22394077
references: J Clin Invest. 2006 Sep;116(9):2344-55
references: 16932810
references: Nat Cell Biol. 2001 May;3(5):439-44
references: 11331870
references: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references: 18287387
references: Mol Cell Biol. 2002 Nov;22(21):7512-23
references: 12370298
references: Nat Cell Biol. 2007 Oct;9(10):1102-9
references: 17909521
references: J Comput Chem. 2011 Jul 30;32(10):2149-59
references: 21541955
references: J Chem Inf Model. 2011 Oct 24;51(10):2778-86
references: 21919503